IL9 and diffuse large B-cell lymphoma: Activator protein-1 (AP-1) could enhance the interactions of IRF-8 with other signaling molecules, while the exact roles of IL-9 and IRF-8 in DLBCL, as well as their relationships with AP-1 family members have still remained elusive.